Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Androgen receptor agonists as breast cancer therapeutics

Models of estrogen receptor–positive breast cancer are used to explore the rationale for androgen receptor agonists as treatments for breast cancer.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: AR and ER signaling and crosstalk in breast cancer.


  1. 1.

    Hickey, T.E. et al. Nat. Med. (2020).

  2. 2.

    Adair, F. E. & Herrmann, J. B. Ann. Surg. 123, 1023–1035 (1946).

    Article  Google Scholar 

  3. 3.

    Kelley, R. M. Cancer 28, 1686–1691 (1971).

    CAS  Article  Google Scholar 

  4. 4.

    Hu, R. et al. Clin. Cancer Res. 17, 1867–1874 (2011).

    CAS  Article  Google Scholar 

  5. 5.

    Vera-Badillo, F. E. et al. J. Natl. Cancer Inst. 106, djt319 (2014).

    Article  Google Scholar 

  6. 6.

    Palmieri, C. et al. San Antonio Breast Cancer Symposium!/9223/presentation/850 (2020).

  7. 7.

    Michmerhuizen, A. R., Spratt, D. E., Pierce, L. J. & Speers, C. W. NPJ Breast Cancer 6, 47 (2020).

    CAS  Article  Google Scholar 

  8. 8.

    Krop, I. et al. Clin. Cancer Res. 26, 6149–6157 (2020).

    CAS  Article  Google Scholar 

  9. 9.

    Garay, J. P. & Park, B. H. Am. J. Cancer Res. 2, 434–445 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. 10.

    D’Amato, N. C. et al. Mol. Cancer Res. 14, 1054–1067 (2016).

    Article  Google Scholar 

  11. 11.

    Schiff, R., Massarweh, S., Shou, J. & Osborne, C. K. Clin. Cancer Res. 9, 447S–454S (2003).

    CAS  Google Scholar 

  12. 12.

    Arruabarrena-Aristorena, A. et al. Cancer Cell (2020).

Download references

Author information



Corresponding authors

Correspondence to Jennifer L. Caswell-Jin or Christina Curtis.

Ethics declarations

Competing interests

C.C. has performed advisory board and/or consulting work for Genentech, GRAIL, Illumina and NanoString, and reports GRAIL stockholdings.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Caswell-Jin, J.L., Curtis, C. Androgen receptor agonists as breast cancer therapeutics. Nat Med 27, 198–199 (2021).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing